• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬血管肿瘤中β-肾上腺素能受体的基因表达谱:初步研究。

Gene expression profiles of beta-adrenergic receptors in canine vascular tumors: a preliminary study.

机构信息

Department of Animal Medicine and Surgery, Universitat Autònoma de Barcelona, 08193, Barcelona, Spain.

Department of Cell Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, 08193, Barcelona, Spain.

出版信息

BMC Vet Res. 2022 May 30;18(1):206. doi: 10.1186/s12917-022-03317-1.

DOI:10.1186/s12917-022-03317-1
PMID:35637463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9150297/
Abstract

Beta adrenergic receptors (β-AR) play a key role in regulating several hallmark pathways of both benign and malignant human and canine tumors. There is scarce information on the expression of β-AR in canine vascular tumors. Therefore, the purpose of the present research work was to study the mRNA expression levels of the three subtypes of the β-AR genes (ADRB1, ADRB2, ADRB3) in hemangiosarcoma (HSA) and hemangioma (HA), as well as in vascular hamartomas (VH) from dogs.Fifty samples (n = 50) were obtained from 38 dogs. Twenty-three animals had HSA, eight animals HA and seven animals VH. HSA were auricular (n = 8), splenic (n = 5), cutaneous (n = 6), auricular and splenic (n = 2), cutaneous-muscular (n = 1) and disseminated (n = 1). There were seven cases of HSA that were divided into primary tumor and secondary (metastatic) tumor. Skin and muscle samples with a normal histological study were used as control group. ADRB gene expression was determinate in all samples by real-time quantitative PCR. Results showed that ADRB1, ADRB2 and ADRB3 were overexpressed in HSA when compared to the control group. ADRB2 was overexpressed in HA when compared to the control group. HSA express higher values of ADBR1 (p = 0.0178) compared to VH. There was a high inter-individual variability in the expression of the three subtypes of ADBR. No statistically significant difference in the expression of ADBR genes were observed between HSA primary when compared to metastatic or in different anatomical locations. In conclusion, canine HSA overexpress the three β-AR subtypes and canine HA β2-AR. High variability was observed in β-AR mRNA levels amongst HSA cases.

摘要

β肾上腺素能受体(β-AR)在调节人类和犬良性和恶性肿瘤的几个标志性途径中起着关键作用。关于犬血管肿瘤中β-AR 的表达信息很少。因此,本研究工作的目的是研究三种β-AR 基因亚型(ADRB1、ADRB2、ADRB3)在血管肉瘤(HSA)和血管瘤(HA)以及犬血管错构瘤(VH)中的 mRNA 表达水平。

从 38 只狗中获得了 50 个样本(n=50)。23 只动物患有 HSA,8 只动物患有 HA,7 只动物患有 VH。HSA 为耳(n=8)、脾(n=5)、皮肤(n=6)、耳脾(n=2)、皮肤肌肉(n=1)和弥散性(n=1)。有 7 例 HSA 分为原发性肿瘤和继发性(转移性)肿瘤。皮肤和肌肉样本组织学检查正常,作为对照组。所有样本均通过实时定量 PCR 测定 ADRB 基因表达。结果表明,与对照组相比,HSA 中 ADRB1、ADRB2 和 ADRB3 过度表达。与对照组相比,HA 中 ADRB2 过度表达。与 VH 相比,HSA 表达更高水平的 ADBR1(p=0.0178)。ADRB 三种亚型的表达存在个体间高度差异。HSA 原发性与转移性或不同解剖部位之间,ADRB 基因的表达无统计学差异。结论是,犬 HSA 过度表达三种β-AR 亚型和犬 HAβ2-AR。在 HSA 病例中,β-AR mRNA 水平存在高度变异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e399/9150297/842dd9ea9bbd/12917_2022_3317_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e399/9150297/9c09b03c2487/12917_2022_3317_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e399/9150297/0197c6b9349e/12917_2022_3317_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e399/9150297/842dd9ea9bbd/12917_2022_3317_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e399/9150297/9c09b03c2487/12917_2022_3317_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e399/9150297/0197c6b9349e/12917_2022_3317_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e399/9150297/842dd9ea9bbd/12917_2022_3317_Fig3_HTML.jpg

相似文献

1
Gene expression profiles of beta-adrenergic receptors in canine vascular tumors: a preliminary study.犬血管肿瘤中β-肾上腺素能受体的基因表达谱:初步研究。
BMC Vet Res. 2022 May 30;18(1):206. doi: 10.1186/s12917-022-03317-1.
2
Expression of platelet-derived growth factor and its receptors in spontaneous canine hemangiosarcoma and cutaneous hemangioma.血小板衍生生长因子及其受体在自发性犬血管肉瘤和皮肤血管瘤中的表达。
Histol Histopathol. 2012 May;27(5):601-7. doi: 10.14670/HH-27.601.
3
Analysis of genomic mutation and immunohistochemistry of platelet-derived growth factor receptors in canine vascular tumours.犬血管肿瘤中血小板衍生生长因子受体的基因组突变与免疫组织化学分析
Vet Comp Oncol. 2015 Sep;13(3):237-45. doi: 10.1111/vco.12035. Epub 2013 Apr 24.
4
Expression of the anti-apoptotic factors Bcl-2 and survivin in canine vascular tumours.抗凋亡因子Bcl-2和生存素在犬血管肿瘤中的表达
J Comp Pathol. 2008 Jul;139(1):1-7. doi: 10.1016/j.jcpa.2008.02.001. Epub 2008 May 13.
5
Surgical treatment of conjunctival hemangioma and hemangiosarcoma: A retrospective study of 52 dogs.结膜血管瘤和血管肉瘤的手术治疗:52 例犬的回顾性研究。
Vet Ophthalmol. 2021 Sep;24(5):432-441. doi: 10.1111/vop.12921. Epub 2021 Aug 17.
6
Immunohistochemical analysis of ocular hemangiomas and hemangiosarcomas in dogs.犬眼部血管瘤和血管肉瘤的免疫组织化学分析
Vet Ophthalmol. 2009 Mar-Apr;12(2):83-90. doi: 10.1111/j.1463-5224.2008.00684.x.
7
Immunohistochemical Detection of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor in Canine Vascular Endothelial Tumours.犬血管内皮肿瘤中尿激酶型纤溶酶原激活剂和尿激酶型纤溶酶原激活剂受体的免疫组织化学检测
J Comp Pathol. 2015 Nov;153(4):278-82. doi: 10.1016/j.jcpa.2015.07.003. Epub 2015 Aug 15.
8
An immunohistochemical analysis of canine haemangioma and haemangiosarcoma.犬血管瘤和血管肉瘤的免疫组织化学分析
J Comp Pathol. 2009 Feb-Apr;140(2-3):158-68. doi: 10.1016/j.jcpa.2008.10.006. Epub 2008 Dec 17.
9
Big endothelin-1 as a tumour marker for canine haemangiosarcoma.大内皮素-1作为犬血管肉瘤的肿瘤标志物。
Vet J. 2015 Jun;204(3):269-74. doi: 10.1016/j.tvjl.2015.03.024. Epub 2015 Mar 25.
10
Chromatin run-on sequencing analysis finds that ECM remodeling plays an important role in canine hemangiosarcoma pathogenesis.染色质转录延伸测序分析发现,细胞外基质重塑在犬血管肉瘤发病机制中发挥重要作用。
BMC Vet Res. 2020 Jun 22;16(1):206. doi: 10.1186/s12917-020-02395-3.

引用本文的文献

1
Androgen Receptors in Human Breast Cancer and Female Canine Mammary Tumors.人类乳腺癌和雌性犬乳腺肿瘤中的雄激素受体
Molecules. 2025 Mar 22;30(7):1411. doi: 10.3390/molecules30071411.

本文引用的文献

1
Propranolol Sensitizes Vascular Sarcoma Cells to Doxorubicin by Altering Lysosomal Drug Sequestration and Drug Efflux.普萘洛尔通过改变溶酶体药物隔离和药物外排使血管肉瘤细胞对阿霉素敏感。
Front Oncol. 2021 Feb 1;10:614288. doi: 10.3389/fonc.2020.614288. eCollection 2020.
2
Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models.普萘洛尔通过β1 肾上腺素能受体拮抗作用抑制动物模型海绵体血管畸形。
J Clin Invest. 2021 Feb 1;131(3). doi: 10.1172/JCI144893.
3
Current Therapies and New Targets to Fight Melanoma: A Promising Role for the β3-Adrenoreceptor.
对抗黑色素瘤的当前疗法与新靶点:β3肾上腺素能受体的潜在作用
Cancers (Basel). 2020 May 30;12(6):1415. doi: 10.3390/cancers12061415.
4
β-Adrenoceptor Blockade for Infantile Hemangioma Therapy: Do β3-Adrenoceptors Play a Role?β-肾上腺素能受体阻滞剂用于婴儿血管瘤治疗:β3-肾上腺素能受体起作用吗?
J Vasc Res. 2018;55(3):159-168. doi: 10.1159/000489956. Epub 2018 Jun 22.
5
Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma.非选择性β受体阻滞剂可抑制血管肉瘤细胞的活力,并提高转移性血管肉瘤患者的无进展生存期和总生存期。
Oncoscience. 2018 Apr 29;5(3-4):109-119. doi: 10.18632/oncoscience.413. eCollection 2018 Mar.
6
Pathobiology of Hemangiosarcoma in Dogs: Research Advances and Future Perspectives.犬血管肉瘤的病理生物学:研究进展与未来展望
Vet Sci. 2015 Nov 6;2(4):388-405. doi: 10.3390/vetsci2040388.
7
Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma.β肾上腺素能信号传导:血管肉瘤和血管内皮肉瘤的一个可靶向调节因子。
Vet Sci. 2015 Sep 21;2(3):270-292. doi: 10.3390/vetsci2030270.
8
Beta-adrenergic receptors are expressed across diverse cancers.β-肾上腺素能受体在多种癌症中均有表达。
Oncoscience. 2017 Aug 23;4(7-8):95-105. doi: 10.18632/oncoscience.357. eCollection 2017 Jul.
9
Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer.在早期乳腺癌中,使用非选择性β受体阻滞剂与肿瘤增殖指数降低有关。
Oncotarget. 2017 Jan 24;8(4):6446-6460. doi: 10.18632/oncotarget.14119.
10
β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives.β-肾上腺素能对癌细胞增殖的调节:现有证据及临床前景
J Cancer Res Clin Oncol. 2017 Feb;143(2):275-291. doi: 10.1007/s00432-016-2278-1. Epub 2016 Oct 5.